Summary
- Current Price
- As of today, XBI price is $155.03, down -0.65% on
- Current Price vs All-Time High
- XBI price is currently -11.30% below its historical high of $174.79 set on
- Dividend Yield
- XBI current TTM dividend yield is 0.37%
Profile
| Metric | Value |
|---|---|
| Name | State Street SPDR S&P Biotech ETF |
| Assets Under Management | $7.87B |
| Expense Ratio | 0.35% |
| Asset Class | Equity |
| Domicile | US |
| Inception Date | |
| Net Asset Value | 123.91K USD |
| Website | ssga.com |
| Last Ex-Dividend Date | |
| Next Ex-Dividend Date | N/A |
Top 30 Holdings
| Name | Ticker | Weight |
|---|---|---|
| MRNA | 2.33% | |
| ROIV | 1.84% | |
| ACLX | 1.72% | |
| PCVX | 1.68% | |
| RVMD | 1.61% | |
| FOLD | 1.53% | |
| GILD | 1.50% | |
| PRAX | 1.49% | |
| AMGN | 1.46% | |
| BMRN | 1.42% | |
| CELC | 1.42% | |
| CGON | 1.38% | |
| MIRM | 1.38% | |
| KRYS | 1.36% | |
| HALO | 1.35% | |
| BIIB | 1.33% | |
| REGN | 1.32% | |
| ABBV | 1.30% | |
| CYTK | 1.30% | |
| VRTX | 1.30% | |
| SRRK | 1.29% | |
| INCY | 1.28% | |
| EXAS | 1.28% | |
| EXEL | 1.26% | |
| PTGX | 1.26% | |
| UTHR | 1.26% | |
| CRSP | 1.25% | |
| ALKS | 1.24% | |
| TWST | 1.20% | |
| IONS | 1.20% |
Chart
SUGGESTED SERIES
Technicals
| Metric | Value | Date |
|---|---|---|
| $155.03 | ||
| $137.99 | ||
| $157.73 | ||
| $139.11 | ||
| $156.80 | ||
| -$0.94 | ||
| 1.06 | ||
| $4.24 | ||
| 44.19 | ||
| 32.52% |
Dividends
| Metric | Value | Date |
|---|---|---|
| $0.14 | ||
| Upcoming | N/A | N/A |
| 0.37% | ||
| $0.57 |
Country Weights
| Country | Weight |
|---|---|
| United States | 94.68% |
| United Kingdom | 1.66% |
| Ireland | 1.51% |
| Switzerland | 1.13% |
| Netherlands | 0.84% |
Sector Weights
| Sector | Weight |
|---|---|
| Healthcare | 99.81% |
FAQ
- Does XBI pay dividends?
- Yes, the State Street SPDR S&P Biotech ETF does pays dividends, with the most recent payment being $0.14 per share. The last ex-dividend date was on June 22, 2026, and the next ex-dividend date has not been announced yet
- What stocks are in XBI?
- As of today, State Street SPDR S&P Biotech ETF includes 153 holdings, with 143 of them being companies from 5 different countries and 1 sectors. The most weighted holdings are Moderna, Inc. (2.33%), Roivant Sciences Ltd. (1.84%) and Arcellx Inc (1.72%)
- What is the current assets under management for XBI?
- Assets under management of State Street SPDR S&P Biotech ETF is $8B
- What is XBI average volume?
- Average volume of State Street SPDR S&P Biotech ETF is $11M
- What is XBI expense ratio?
- Expense ratio of State Street SPDR S&P Biotech ETF is 0.35%
- What is XBI inception date?
- Inception date of State Street SPDR S&P Biotech ETF is January 31, 2006
Data Sources & References
- XBI Official Website www.ssga.com/us/en/institutional/etfs/state-street-spdr-sp-biotech-etf-xbi
- XBI Profile on Yahoo Finance finance.yahoo.com/quote/XBI